The Endotracheal Tubes Market size was valued at USD 859.36 million in 2024 and is projected to reach USD 1217.85 million by 2033, growing at a CAGR of 3.95% (2025–2033). This growth is primarily fueled by the surge in chronic respiratory conditions and the rising number of surgical interventions globally.
Market Highlights
- North America held the largest share in 2024, valued at USD 343.7 million (40%), and is expected to expand at a CAGR of 3.08%.
- By intubation type, the oral (orotracheal) segment dominated with 68.7% share in 2024 and is forecasted to grow at a CAGR of 4.22%.
- By product type, the uncuffed segment led the market in 2024, expanding at a CAGR of 3.89%, largely due to pediatric usage.
- By application, anesthesia and critical care accounted for the highest share in 2024, with a projected CAGR of 3.72%.
- The Asia-Pacific region is set to witness the fastest growth during the forecast period, driven by rising respiratory cases, hospital admissions, and healthcare advancements.
Growth Drivers
- Prevalence of Chronic Respiratory Diseases: COPD, asthma, tuberculosis, and lung cancer remain leading causes of mortality and morbidity. Endotracheal intubation plays a vital role in managing these conditions and ensuring controlled ventilation. Antimicrobial-coated ETs are also enhancing safety and reducing biofilm risks.
- Rising Number of Surgeries: With 234 million major surgical procedures performed annually worldwide (WHO), demand for airway management through ETs continues to rise, particularly in orthopedic, bariatric, gynecological, and gastrointestinal surgeries.
Market Restraints
- Lack of skilled professionals and risks of post-surgery complications, such as throat soreness and voice changes, pose challenges to wider adoption.
Opportunities Ahead
- Video Laryngoscopy for ETI: The integration of video laryngoscopes improves glottis visualization, increases first-pass success, and minimizes risks. Particularly in ICUs and during COVID-19, video laryngoscopy has proven highly effective, creating opportunities for expanded ET adoption.
Regional Insights
- North America: Growth fueled by a high burden of asthma (over 25 million Americans) and COPD (16 million adults).
- Europe: Rising elderly population and respiratory issues, with nearly 66 million people living with COPD.
- Asia-Pacific: Fastest growth, driven by a surge in NICU/PICU admissions, respiratory injuries, and demand for coated ETs.
- Latin America & MEA: High COPD and asthma prevalence along with increased surgical procedures and medical tourism boost adoption.
Key Players
- Medtronic
- Teleflex
- Smiths Medical
- Vygon
- Angiplast
- Medline Industries
- Sharklet Technologies
- Sterimed
- ConvaTec
- Intersurgical
- Securmed
- Bactiguard AB
Recent Developments
- January 2023: Timesco Healthcare launched a new video laryngoscope at Arab Health 2023 to aid difficult intubations.
- September 2022: Medtronic recalled 625,700 endotracheal tubes globally due to potential airway obstruction risks.
Conclusion
The global endotracheal tubes market is set for steady growth as respiratory health challenges and surgical volumes continue to rise. With innovations like video laryngoscopy and antimicrobial coatings, the market is poised for advancements that enhance patient safety and efficiency.
About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.
Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/
